Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert…
Read More
London’s CHARM Therapeutics raises €68.5 million financing to tackle treatment-resistant cancers
British BioTech startup CHARM Therapeutics, announces closing of an oversubscribed Series B funding round, raising €68.5 million to advance its…
Read More
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn, with…
Read More
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program relocating into full development…
Read More
Paris-based FemTech app Solence raises €1.6 million to address PCOS with AI-driven digital therapeutics
French startup Solence, an app that supports women suffering from Polycystic Ovary Syndrome (PCOS), has raised €1.6 million in Seed…
Read More
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra’s phase…
Read More
Nimbus Therapeutics Announces Clinical Progress in Oncology Therapeutic Pipeline and Provides Business Updates
— Completion of IND submission for NDI-219216, a non-covalent WRN inhibitor for treatment of MSI-H tumors, with plans to initiate…
Read More
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
The company will file the NDA for BRIMOCHOL™ PF, a once-a-day eye drop for the treatment of presbyopia, with a…
Read More
London-based beginup Laverock Therapeutics raises over €23.3 million for its gene control tech
British HealthTech beginup Laverock Therapeutics, a gene control company focapplyd on the development of disease-responsive advanced therapies, announced the expansion…
Read More
